Bette Caan to Estrogen Replacement Therapy
This is a "connection" page, showing publications Bette Caan has written about Estrogen Replacement Therapy.
Connection Strength
1.564
-
Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2008 Apr 16; 100(8):597-8; author reply 599.
Score: 0.298
-
Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med. 2004 Mar 04; 350(10):991-1004.
Score: 0.225
-
CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk. Br J Cancer. 2016 Jan 19; 114(2):221-9.
Score: 0.128
-
Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial. Menopause. 2015 Jun; 22(6):607-15.
Score: 0.122
-
Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial. JAMA Intern Med. 2014 Jul; 174(7):1058-66.
Score: 0.115
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002 Jul 17; 288(3):321-33.
Score: 0.100
-
Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2009 Nov; 18(11):3079-85.
Score: 0.083
-
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA. 2008 Mar 05; 299(9):1036-45.
Score: 0.074
-
Effect of hormone therapy on risk of hip and knee joint replacement in the Women's Health Initiative. Arthritis Rheum. 2006 Oct; 54(10):3194-204.
Score: 0.067
-
Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. Maturitas. 2006 Sep 20; 55(2):103-15.
Score: 0.066
-
Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA. 2006 Apr 12; 295(14):1647-57.
Score: 0.065
-
Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. Am J Epidemiol. 2006 Apr 01; 163(7):589-99.
Score: 0.064
-
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004 Apr 14; 291(14):1701-12.
Score: 0.057
-
Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control. 1997 Mar; 8(2):146-58.
Score: 0.035
-
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998 Feb; 19(1):61-109.
Score: 0.018
-
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006 Feb 16; 354(7):669-83.
Score: 0.016
-
Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006 Feb 08; 295(6):643-54.
Score: 0.016
-
Sex-specific differences in colon cancer associated with p53 mutations. Nutr Cancer. 2004; 49(1):41-8.
Score: 0.014